NeoBiocon partners Novartis to launch diabetes drugs in UAE
NeoBiocon, a collaboration between Biocon Ltd and BR Shetty led UAE-based Neopharma, has partnered with Novartis Middle East FZE to market diabetes drugs Jalra and Jalra-M in the UAE.
Dec 09, 2015, 22:55 PM IST
Novartis gets USFDA warning letter for two plants in India
Sandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of current good manufacturing practice (cGMP) norms at its two plants in Western India.
Oct 28, 2015, 21:05 PM IST
GSK Pharma completes deal with Novartis Healthcare
The company has completed its transaction with Novartis Healthcare Pvt Ltd Wednesday whereby it has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis India, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
Sep 30, 2015, 20:37 PM IST
Novartis flags margin increase, higher dividends, bolt-on deals
Novartis AG said on Thursday it expects to increase its profit margin this year as it restructures its drug portfolio and cuts costs, as well as generate cash for a higher dividend and smaller, strategic acquisitions.
Jun 18, 2015, 17:59 PM IST
Ready to pay "reasonable" royalty to Novartis AG: Cipla to HC
Indian pharma firm Cipla Monday suggested to the Delhi High Court that it was ready to pay "reasonable" royalty to Switzerland-based drug major Novartis AG if it is allowed to manufacture respiratory disease drug, 'Indaflo', which could serve 66,000 patients in India at a cheaper rate.
Apr 27, 2015, 23:21 PM IST
Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr
Novartis India's board on Tuesday approved the sale of its OTC division to GlaxoSmithKline Consumer Pvt Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore.
Jan 13, 2015, 19:15 PM IST
Novartis sues India's Cipla over respiratory drug Onbrez
Swiss drugmaker Novartis AG said on Wednesday it had sued India`s Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug`s price.
Dec 17, 2014, 19:21 PM IST
World's top drugmaker Novartis takes aim at tech
Talent spotters from Novartis AG, charged with bringing new ideas into the organisation, are casting their net beyond biotech into the wider pool of wearable, or even edible, technology.
Nov 18, 2014, 15:08 PM IST
